Synonyms: | |
Status: | Phase 2 |
Entry Type: | Small molecule |
Molecule Category: | UKNOWN |
UNII: | NR9ZYH80Z8 |
InChI Key | BEMNJULZEQTDJY-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C20H16N6O |
Molecular Weight | 356.39 |
AlogP | 3.35 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 3.0 |
Number of Rotational Bond | 3.0 |
Polar Surface Area | 105.38 |
Molecular species | NEUTRAL |
Aromatic Rings | 5.0 |
Heavy Atoms | 27.0 |
Action | Mechanism of Action | Reference |
---|---|---|
INHIBITOR | Fibroblast growth factor receptor 1 inhibitor | PubMed ClinicalTrials |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase FGFR family
|
- | 22-22 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase Src family
|
- | 5900 | - | - | - | |
Enzyme
Kinase
Protein Kinase
TK protein kinase group
Tyrosine protein kinase VEGFR family
|
- | 2100-2100 | - | - | - | |
Ion channel
Voltage-gated ion channel
Potassium channels
Voltage-gated potassium channel
|
- | 6900 | - | - | 69 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Neoplasms | 2 | D009369 | ClinicalTrials |
Breast Neoplasms | 1 | D001943 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL3907479 |
DrugBank | DB12903 |
FDA SRS | NR9ZYH80Z8 |
Guide to Pharmacology | 9787 |
PDB | LWJ |
SureChEMBL | SCHEMBL10002991 |
ZINC | ZINC000098209140 |